Custom gene synthesis

This is a Notice of Intent to award, not a request for Quotation.  The National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) intends to negotiate on an other than full and open competition basis with Genscript USA Incorporated for Custom Gene Synthesis. This request will include DNA synthesis sequences we designed based on the VRC neutralization-panel of viruses, subcloning of the synthesized sequences into two different expression vectors, and preparation DNA for plasmids. The results from these services will be used at NIH for continued HIV studies within the Vaccine Research Center in Bethesda, MD  

The Place of performance NIH, VACCINE RESEARCH CENTER 40 CONVENT DR BETHESDA, MD  20892 

The statutory authority for this sole source requirement is 41 U.S.C.1901 (e) (2) as implemented by FAR 13.106-1 only one responsible source and no other supply of  service will satisfy agency requirements. THIS IS NOT A REQUEST FOR 
QUOTES.  All responsible sources that could provide comparable services may submit a capability statement that will be considered by email (subject line to reference NOI-RML-C-2032389 to Diana Rohlman at diana.rohlman@nih.gov by  9:00 AM Mountain Standard Time, August 3, 2020.  All compatibility responses received by the closing date of this synopsis will be considered by the Government.  

 A determination not to compete this requirement, based upon responses to this notice, is solely within the discretion of the Government.